| Mr Samuel Bundu-kamara, PHARMACIST | |
|
1950 E Fry Blvd, Sierra Vista, AZ 85635-2705 | |
| (520) 458-5638 | |
| Not Available |
| Full Name | Mr Samuel Bundu-kamara |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1950 E Fry Blvd, Sierra Vista, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285964379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | S016954 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Samuel Bundu-kamara, PHARMACIST 1950 E Fry Blvd, Sierra Vista, AZ 85635-2705 Ph: (520) 458-5638 | Mr Samuel Bundu-kamara, PHARMACIST 1950 E Fry Blvd, Sierra Vista, AZ 85635-2705 Ph: (520) 458-5638 |
News Archive
Research just published that identifies new highly antibiotic-resistant bacteria reinforces the frequency with which similar strains of so-called "superbugs" are being discovered across Europe, according to the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
PharmaTrust, makers of the world's leading remote prescription drug dispensing technology, has signed an agreement with the Ontario Telemedicine Network that will enable OTN's Members, including hospitals, to integrate PharmaTrust's technology into their telemedicine service offering. This new development will expand access to valuable pharmacy services for Ontarians.
Boehringer Ingelheim and Priaxon entered into a worldwide collaboration to research and develop mdm2/p53 inhibitors for the treatment of cancer. Priaxon is providing its innovative and proprietary small molecule drug discovery expertise which is particularly suited to investigate inhibition of protein-protein interactions. p53 is a human tumor suppressor protein.
DNA methylation has been identified as a potential biomarker of response to etanercept and adalimumab in patients with rheumatoid arthritis (RA) according to preliminary results from one of the largest methylome-wide investigations of treatment response to anti-TNF therapies.
People who have questions about the H1N1 flu can get answers from infectious disease experts at Rush University Medical Center during a one-hour, live Facebook chat to be held on Friday, November 20 from12 p.m. until 1 p.m.
› Verified 4 days ago
David Andrew Merrell, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 155 Calle Portal Ste 600, Sierra Vista, AZ 85635 Phone: 520-515-8678 | |
Brian Dean Renoud, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 N Highway 90 Byp, Sierra Vista, AZ 85635 Phone: 520-458-9690 | |
Danielle Taylor, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 S Highway 92, Sierra Vista, AZ 85635 Phone: 520-439-6081 Fax: 520-439-6083 | |
Laura Buckley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 N Highway 90 Byp, Sierra Vista, AZ 85635 Phone: 520-458-9690 Fax: 520-458-8729 | |
Janice Johnson-cook, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 N Highway 90 Byp, Sierra Vista, AZ 85635 Phone: 520-458-9690 | |
Anthony Roether, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1939 Frontage Rd Ste B, Sierra Vista, AZ 85635 Phone: 520-459-0705 | |
Hanna Nicolle Bokaie, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1950 E Fry Blvd, Sierra Vista, AZ 85635 Phone: 520-458-5638 |